Rising opioid-associated skin and soft tissue infections and the emerging threat of xylazine: A national analysis
- 6 June 2025
- journal article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 274, 112739
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (UL1TR003142)
This publication has 51 references indexed in Scilit:
- Xylazine in Overdose Deaths and Forensic Drug Reports in US States, 2019-2022JAMA Network Open, 2024
- Medical Costs of Substance Use Disorders in the US Employer-Sponsored Insurance PopulationJAMA Network Open, 2023
- Disparities by Sex and Race and Ethnicity in Death Rates Due to Opioid Overdose Among Adults 55 Years or Older, 1999 to 2019JAMA Network Open, 2022
- Problematic Opioid Use Among Older Adults: Epidemiology, Adverse Outcomes and Treatment ConsiderationsDrugs & Aging, 2021
- A randomized controlled trial of a brief behavioral intervention to reduce skin and soft tissue infections among people who inject drugsDrug and Alcohol Dependence, 2021
- Impact of medications for opioid use disorder among persons hospitalized for drug use-associated skin and soft tissue infectionsDrug and Alcohol Dependence, 2020
- Self-treatment of skin infections by people who inject drugsDrug and Alcohol Dependence, 2020
- Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United StatesJAMA Network Open, 2019
- Sex work, injection drug use, and abscesses: Associations in women, but not menDrug and Alcohol Dependence, 2018
- Nationwide increase in hospitalizations for heroin-related soft tissue infections: Associations with structural market conditionsDrug and Alcohol Dependence, 2016